Bruker Corporation (BRKR) - Total Liabilities
Based on the latest financial reports, Bruker Corporation (BRKR) has total liabilities worth $3.73 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Bruker Corporation annual equity growth to track the company's year-over-year net asset growth rate.
Bruker Corporation - Total Liabilities Trend (1998–2025)
This chart illustrates how Bruker Corporation's total liabilities have evolved over time, based on quarterly financial data. See BRKR free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Bruker Corporation Competitors by Total Liabilities
The table below lists competitors of Bruker Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PrairieSky Royalty Ltd
TO:PSK
|
Canada | CA$630.60 Million |
|
Jiangsu Leadmicro Nano Technology Co. Ltd. A
SHG:688147
|
China | CN¥5.54 Billion |
|
Motiva Infraestrutura de Mobilidade S.A.
SA:MOTV3
|
Brazil | R$59.38 Billion |
|
eMemory Technology
TWO:3529
|
Taiwan | NT$889.20 Million |
|
Samsung Engineering
KO:028050
|
Korea | ₩5.59 Trillion |
|
Inner Mongolia Dazhong Mining Co Ltd
SHE:001203
|
China | CN¥10.41 Billion |
|
Yanzhou Coal Mining Company Limited
F:YZC
|
Germany | €291.25 Billion |
|
Vipshop Holdings Limited
F:1VPA
|
Germany | €34.40 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Bruker Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bruker Corporation (BRKR) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bruker Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bruker Corporation (1998–2025)
The table below shows the annual total liabilities of Bruker Corporation from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.73 Billion | -6.52% |
| 2024-12-31 | $3.99 Billion | +40.71% |
| 2023-12-31 | $2.84 Billion | +14.38% |
| 2022-12-31 | $2.48 Billion | -3.32% |
| 2021-12-31 | $2.57 Billion | +23.64% |
| 2020-12-31 | $2.07 Billion | +13.17% |
| 2019-12-31 | $1.83 Billion | +49.84% |
| 2018-12-31 | $1.22 Billion | +0.70% |
| 2017-12-31 | $1.22 Billion | +8.50% |
| 2016-12-31 | $1.12 Billion | +12.20% |
| 2015-12-31 | $998.00 Million | -8.70% |
| 2014-12-31 | $1.09 Billion | -3.95% |
| 2013-12-31 | $1.14 Billion | -0.76% |
| 2012-12-31 | $1.15 Billion | +5.64% |
| 2011-12-31 | $1.09 Billion | +6.18% |
| 2010-12-31 | $1.02 Billion | +35.74% |
| 2009-12-31 | $753.20 Million | -6.27% |
| 2008-12-31 | $803.60 Million | +173.32% |
| 2007-12-31 | $294.02 Million | +21.75% |
| 2006-12-31 | $241.48 Million | +57.98% |
| 2005-12-31 | $152.85 Million | -0.80% |
| 2004-12-31 | $154.08 Million | +3.77% |
| 2003-12-31 | $148.48 Million | +93.53% |
| 2002-12-31 | $76.72 Million | +24.70% |
| 2001-12-31 | $61.53 Million | +1.90% |
| 2000-12-31 | $60.38 Million | +5.47% |
| 1999-12-31 | $57.25 Million | +7.01% |
| 1998-12-31 | $53.50 Million | -- |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, ser… Read more